I joined Clearwater in 2019 to support M&A advisory within the Healthcare team and to help build Clearwater’s life sciences practice. I have over 8 years’ experience in corporate finance and have advised a broad range of companies and financial investors globally on M&A transactions, with an aggregate value of c. €3.5bn.
Prior to joining Clearwater, I held Healthcare M&A advisory roles at Lazard and Torreya, predominantly focused on the life sciences sector. Deals which I have advised on include Skyepharma’s all-share merger with Vectura and advising Bain Capital and the UK Department of Health on their disposal of Bio Products Laboratory to Creat Group.
I am a Chartered Accountant, having trained at Deloitte. I hold a BSc in Biological Sciences from the University of Bristol and am a fluent French speaker.